GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 97 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2016. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $7,754,000 | +7.0% | 536,582 | +70.6% | 0.00% | 0.0% |
| Q3 2016 | $7,249,000 | +207.3% | 314,491 | +121.2% | 0.00% | – |
| Q2 2016 | $2,359,000 | +97.9% | 142,197 | +89.2% | 0.00% | – |
| Q1 2016 | $1,192,000 | -52.2% | 75,157 | -2.5% | 0.00% | – |
| Q4 2015 | $2,492,000 | -6.4% | 77,074 | +22.1% | 0.00% | – |
| Q3 2015 | $2,662,000 | – | 63,147 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |